首页> 外文期刊>Hormone and Metabolic Research >Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population
【24h】

Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population

机译:normocalcemic初级甲状旁腺功能亢进:与高等教育人群中高钙血症的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Normocalcemic primary hyperparathyroidism (NPHPT) is a formally recognized variant of primary hyperparathyroidism (PHPT), characterized by normal total and ionized serum calcium concentrations and elevated parathyroid hormone (PTH) levels, in the absence of secondary causes for hyperparathyroidism. NPHPT has been studied previously, but data are limited and confounded. We aimed to compare the clinical and biochemical data of normocalcemic and hypercalcemic subjects in a hospital-based population. We retrospectively analysed the medical records of 131 subjects diagnosed with PHPT at the university hospital Brussels (UZ Brussel) between January 1st 2007 and December 31st 2016, including 25 normocalcemic and 106 hypercalcemic subjects. The mean values of age, BMI, sex, serum 25-OH vitamin D levels and urinary phosphate excretion were comparable between both groups. Subjects diagnosed with NPHPT had significantly lower plasma PTH levels, lower urinary calcium excretion and lower serum creatinine levels compared to the hypercalcemic subjects with PHPT. Corresponding eGFR values were higher in the normocalcemic group. Normocalcemic subjects (NPHPT) presented with a high prevalence of nephrolithiasis (36%), fragility fractures (12%) and osteoporosis (25%). Clinical manifestations and BMD measurements revealed no statistically significant differences between both groups. Our data show a relative prevalence of 19% NPHPT in PHPT. NPHPT may present the earliest form of PHPT with an extension in time, but is not an indolent disease state. Normocalcemic subjects should be managed as hypercalcemic subjects with PHPT. Further research regarding the pathophysiology and natural course of NPHPT is required.
机译:Normocalcemic初级甲脱石亢进症(NPHPT)是一种正式公认的原发性甲状旁腺功能亢进症(PHPT)变体,其特征在于,在没有次离子根瘤品的次要原因的情况下,甲状旁腺激素(PTH)水平升高的甲状旁腺激素(PTH)水平。在此之前已经研究过NPHPT,但数据有限和混淆。我们的旨在比较常规的常规血糖和高钙血症受试者在医院人口中的临床和生化数据。我们回顾性分析了2007年1月1日至2016年12月31日在大学医院布鲁塞尔(Uz Brussel)诊断患有PHPT的131名受试者的病历,其中包括25季诺维曲霉病和106个高钙血症。两组之间的平均值,BMI,性别,血清25-OH维生素D水平和尿磷酸盐排泄等值。与PHPT的高钙质受试者相比,诊断患有NPHPT的受试者显着降低了血浆PTH水平,降低尿钙排泄和血清肌酐水平。 NormoCalcemic群中相应的EGFR值较高。常规血糖受试者(NPHPT)呈现出高肾病(36%),脆性骨折(12%)和骨质疏松症(25%)的高患病率。临床表现和BMD测量显示,两组之间没有统计学上显着的差异。我们的数据显示PHPT中19%NPHPT的相对普及。 NPHPT可以及时延伸最早形式的PHPT,但不是惰性疾病状态。常规血糖受试者应与PHPT一起管理作为高钙糖受试者。需要有关NPHPT的病理生理学和自然过程的进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号